EWTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.11%

Insider Buying (Last 12 Months): $10,000,000.23

Insider Selling (Last 12 Months): $12,738,116.72

Edgewise Therapeutics Insider Trading History Chart

Edgewise Therapeutics Share Price & Price History

^$13.41

▲ +0.376 (2.89%)

As of 04/17/2025 04:59 PM ET

Days: 30 | 90 | 365

Edgewise Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/3/2025	Orbimed Advisors Llc	Director	Buy	496,771	$20.13	$10,000,000.23	14,809,075
2/6/2025	Alan J. Russell	Insider	Sell	1,200	$30.13	$36,156.00	14,863
2/5/2025	Kevin Koch	CEO	Sell	8,636	$30.03	$259,339.08	14,478
1/28/2025	Joanne M. Donovan	CMO	Sell	25,000	$27.63	$690,750.00	16,358
12/30/2024	Alan J. Russell	Insider	Sell	100,000	$27.37	$2,737,000.00	14,863
12/24/2024	Marc Semigran	Insider	Sell	29,709	$29.69	$882,060.21	6,716
9/23/2024	John R Moore	General Counsel	Sell	20,922	$27.63	$578,074.86	3,252
9/20/2024	Alan J. Russell	Insider	Sell	75,000	$28.27	$2,120,250.00	12,719
9/20/2024	Joanne M. Donovan	CMO	Sell	7,162	$28.29	$202,612.98	14,538
9/20/2024	John R Moore	General Counsel	Sell	50,000	$28.37	$1,418,500.00	3,252
9/20/2024	R. Michael Carruthers	CFO	Sell	125,092	$28.57	$3,573,878.44	6,904
5/2/2024	Behrad Derakhshan	Insider	Sell	1,718	$18.91	$32,487.38	13,422
5/2/2024	Joanne M. Donovan	CMO	Sell	3,682	$18.91	$69,626.62	19,897
5/2/2024	John R Moore	General Counsel	Sell	1,956	$18.91	$36,987.96	3,252
5/2/2024	Kevin Koch	CEO	Sell	3,152	$18.91	$59,604.32	14,478
5/2/2024	R. Michael Carruthers	CFO	Sell	2,157	$18.91	$40,788.87	35,230
2/9/2024	John R. Moore	General Counsel	Sell	8,029	$20.01	$160,660.29
2/8/2024	Behrad Derakhshan	Insider	Sell	4,600	$20.01	$92,046.00	7,020
2/7/2024	John R. Moore	General Counsel	Sell	17,993	$20.00	$359,860.00
1/23/2024	Peter A. Thompson	Director	Buy	454,545	$11.00	$4,999,995.00	14,436,497
1/23/2024	R. Michael Carruthers	CFO	Sell	90,000	$15.78	$1,420,200.00	29,024
12/27/2023	John R. Moore	General Counsel	Sell	8,497	$10.50	$89,218.50
12/26/2023	Alan J. Russell	Insider	Sell	172,585	$9.33	$1,610,218.05	3,606
12/26/2023	Jonathan C. Fox	Director	Buy	10,857	$9.30	$100,970.10	10,857
5/2/2023	Behrad Derakhshan	Insider	Sell	1,747	$8.90	$15,548.30	7,020
5/2/2023	Joanne M. Donovan	CMO	Sell	3,254	$8.90	$28,960.60	9,960
5/2/2023	John R Moore	General Counsel	Sell	1,897	$8.90	$16,883.30	6,565
5/2/2023	Kevin Koch	CEO	Sell	3,203	$8.90	$28,506.70	7,213
5/2/2023	R. Michael Carruthers	CFO	Sell	1,336	$8.90	$11,890.40	16,126
10/3/2022	John R Moore	General Counsel	Sell	4,730	$9.76	$46,164.80	3,000
9/16/2022	Peter A. Thompson	Director	Buy	484,496	$10.32	$4,999,998.72	13,981,952
9/14/2022	Holdings A/S Novo	Major Shareholder	Buy	484,496	$10.32	$4,999,998.72	6,071,703
8/3/2022	John R Moore	General Counsel	Sell	9,232	$9.31	$85,949.92	3,000
7/5/2022	John R Moore	General Counsel	Sell	8,186	$8.35	$68,353.10	3,000
6/21/2022	John R Moore	General Counsel	Sell	31,078	$7.29	$226,558.62	3,000
6/17/2022	John R Moore	General Counsel	Sell	22,127	$6.62	$146,480.74	3,000
6/14/2022	John R Moore	General Counsel	Sell	3,628	$6.02	$21,840.56	3,000
6/10/2022	John R Moore	General Counsel	Sell	7,125	$6.05	$43,106.25	3,000
6/7/2022	John R Moore	General Counsel	Sell	18,123	$6.61	$119,793.03	3,000
6/3/2022	John R Moore	General Counsel	Sell	15,230	$6.05	$92,141.50	3,000
5/18/2022	Orbimed Advisors Llc	Director	Buy	138,000	$7.21	$994,980.00	13,497,456
5/16/2022	John R Moore	General Counsel	Sell	10,800	$7.42	$80,136.00	3,000

See Full Table

SEC Filings (Institutional Ownership Changes) for Edgewise Therapeutics (NASDAQ:EWTX)

Institutional Buying and Selling by Quarter

Edgewise Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/15/2025	SG Americas Securities LLC	12,883	$0.28M	0.0%	N/A	0.012%
4/10/2025	Contravisory Investment Management Inc.	10,209	$0.23M	0.0%	N/A	0.010%
4/8/2025	Rhumbline Advisers	108,837	$2.39M	0.0%	+6.3%	0.104%
4/7/2025	GAMMA Investing LLC	30,954	$0.68M	0.0%	+2,243.2%	0.030%
3/24/2025	Wellington Management Group LLP	202,893	$5.42M	0.0%	-1.2%	0.213%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	90,031	$2.40M	0.0%	N/A	0.095%
2/25/2025	Polar Asset Management Partners Inc.	64,279	$1.72M	0.0%	-59.2%	0.068%
2/19/2025	GF Fund Management CO. LTD.	1,988	$53K	0.0%	N/A	0.002%
2/18/2025	Neo Ivy Capital Management	9,720	$0.26M	0.1%	N/A	0.010%
2/18/2025	Frazier Life Sciences Management L.P.	1,271,245	$33.94M	1.4%	-55.1%	1.343%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	279,125	$7.45M	0.0%	+231.1%	0.295%
2/17/2025	Woodline Partners LP	567,218	$15.15M	0.1%	+7.5%	0.599%
2/17/2025	Soleus Capital Management L.P.	183,300	$4.89M	0.3%	N/A	0.194%
2/17/2025	Squarepoint Ops LLC	26,358	$0.70M	0.0%	+58.5%	0.028%
2/17/2025	Two Sigma Investments LP	131,667	$3.52M	0.0%	-49.6%	0.139%
2/17/2025	Tang Capital Management LLC	300,000	$8.01M	0.5%	N/A	0.317%
2/17/2025	Stempoint Capital LP	132,706	$3.54M	0.9%	+566.9%	0.140%
2/17/2025	Rafferty Asset Management LLC	11,906	$0.32M	0.0%	-10.1%	0.013%
2/17/2025	Point72 Asset Management L.P.	106,562	$2.85M	0.0%	N/A	0.113%
2/17/2025	Polar Asset Management Partners Inc.	64,279	$1.72M	0.0%	-59.2%	0.068%
2/17/2025	ProShare Advisors LLC	24,928	$0.67M	0.0%	+29.4%	0.026%
2/17/2025	MPM Bioimpact LLC	1,079,316	$28.82M	4.1%	+17.7%	1.140%
2/17/2025	Paradigm Biocapital Advisors LP	4,493,929	$119.99M	4.2%	+61.1%	4.746%
2/17/2025	Parkman Healthcare Partners LLC	381,173	$10.18M	1.4%	-42.0%	0.403%
2/17/2025	Nuveen Asset Management LLC	428,858	$11.45M	0.0%	+58.6%	0.453%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	41,313	$1.10M	0.0%	+4.0%	0.044%
2/17/2025	J. Goldman & Co LP	107,278	$2.86M	0.1%	+82.9%	0.113%
2/17/2025	Janus Henderson Group PLC	4,983,940	$133.04M	0.1%	+9.3%	5.263%
2/17/2025	Graham Capital Management L.P.	18,415	$0.49M	0.0%	+15.8%	0.019%
2/17/2025	Granahan Investment Management LLC	300,013	$8.01M	0.3%	-41.4%	0.317%
2/17/2025	Ensign Peak Advisors Inc	80,509	$2.15M	0.0%	N/A	0.085%
2/17/2025	Deutsche Bank AG	275,837	$7.37M	0.0%	+26.6%	0.291%
2/17/2025	D. E. Shaw & Co. Inc.	686,371	$18.33M	0.0%	+50.7%	0.725%
2/17/2025	DAFNA Capital Management LLC	187,140	$5M	1.3%	-17.9%	0.198%
2/17/2025	Deerfield Management Company L.P. Series C	2,078,509	$55.50M	1.1%	+16.7%	2.195%
2/17/2025	Driehaus Capital Management LLC	1,493,791	$39.88M	0.3%	-23.5%	1.578%
2/17/2025	Deep Track Capital LP	710,421	$18.97M	0.7%	-35.4%	0.750%
2/17/2025	Crestline Management LP	13,268	$0.35M	0.0%	-50.8%	0.014%
2/17/2025	Cubist Systematic Strategies LLC	219,549	$5.86M	0.0%	N/A	0.232%
2/17/2025	Braidwell LP	2,332,196	$62.27M	1.8%	+19.1%	2.463%
2/17/2025	Brevan Howard Capital Management LP	25,346	$0.68M	0.0%	+125.3%	0.027%
2/17/2025	Baker BROS. Advisors LP	6,155,940	$164.36M	1.8%	+5.4%	6.501%
2/17/2025	Balyasny Asset Management L.P.	23,364	$0.62M	0.0%	N/A	0.025%
2/17/2025	Bamco Inc. NY	60,000	$1.60M	0.0%	N/A	0.063%
2/17/2025	Bank of America Corp DE	48,907	$1.31M	0.0%	-84.1%	0.052%
2/17/2025	BNP Paribas Financial Markets	33,082	$0.88M	0.0%	N/A	0.035%
2/17/2025	Ameriprise Financial Inc.	22,584	$0.60M	0.0%	N/A	0.024%
2/17/2025	Algert Global LLC	110,259	$2.94M	0.1%	+1,073.0%	0.116%
2/17/2025	Ally Bridge Group NY LLC	83,176	$2.22M	1.9%	-55.7%	0.088%
2/17/2025	Acuta Capital Partners LLC	87,658	$2.34M	2.4%	+39.1%	0.093%
2/14/2025	Novo Holdings A S	5,000,000	$133.50M	8.1%	-9.9%	5.280%
2/14/2025	Schonfeld Strategic Advisors LLC	268,509	$7.17M	0.0%	-50.8%	0.284%
2/14/2025	First Light Asset Management LLC	780,639	$20.84M	2.0%	N/A	0.824%
2/14/2025	Foresite Capital Management VI LLC	585,000	$15.62M	7.0%	N/A	0.618%
2/14/2025	Northern Trust Corp	611,306	$16.32M	0.0%	+6.2%	0.646%
2/14/2025	The Manufacturers Life Insurance Company	40,170	$1.07M	0.0%	+4.6%	0.042%
2/14/2025	Tudor Investment Corp ET AL	43,809	$1.17M	0.0%	+23.0%	0.046%
2/14/2025	Quarry LP	2,000	$53K	0.0%	-42.9%	0.002%
2/14/2025	Aquatic Capital Management LLC	2,894	$77K	0.0%	N/A	0.003%
2/14/2025	Virtus ETF Advisers LLC	2,526	$67K	0.0%	-50.9%	0.003%
2/14/2025	Voya Investment Management LLC	284,148	$7.59M	0.0%	-7.7%	0.300%
2/14/2025	Adage Capital Partners GP L.L.C.	240,000	$6.41M	0.0%	+1,015.8%	0.253%
2/14/2025	Price T Rowe Associates Inc. MD	29,050	$0.78M	0.0%	+22.0%	0.031%
2/14/2025	Harvest Investment Services LLC	79,381	$2.12M	0.5%	N/A	0.084%
2/14/2025	Diadema Partners LP	1,359	$36K	0.0%	N/A	0.001%
2/14/2025	Hsbc Holdings PLC	10,759	$0.28M	0.0%	+23.3%	0.011%
2/14/2025	Tower Research Capital LLC TRC	3,676	$98K	0.0%	+1,097.4%	0.004%
2/14/2025	MetLife Investment Management LLC	44,612	$1.19M	0.0%	+5.5%	0.047%
2/14/2025	BI Asset Management Fondsmaeglerselskab A S	8,853	$0.24M	0.0%	N/A	0.009%
2/14/2025	Dimensional Fund Advisors LP	729,923	$19.49M	0.0%	+0.4%	0.771%
2/13/2025	Marshall Wace LLP	29,893	$0.80M	0.0%	-94.8%	0.032%
2/13/2025	EAM Investors LLC	91,333	$2.44M	0.3%	-27.0%	0.096%
2/13/2025	Jump Financial LLC	55,178	$1.47M	0.0%	-58.1%	0.058%
2/13/2025	Walleye Capital LLC	198,662	$5.30M	0.0%	-18.0%	0.210%
2/13/2025	New Leaf Venture Partners L.L.C.	1,030,161	$27.51M	36.8%	-33.7%	1.088%
2/13/2025	Barclays PLC	133,657	$3.57M	0.0%	+12.0%	0.141%
2/13/2025	Summit Investment Advisors Inc.	7,594	$0.20M	0.2%	+6.8%	0.008%
2/13/2025	Optimize Financial Inc	12,062	$0.32M	0.2%	N/A	0.013%
2/13/2025	Kennedy Capital Management LLC	236,642	$6.32M	0.1%	+4.2%	0.250%
2/13/2025	Legal & General Group Plc	50,292	$1.34M	0.0%	+5.7%	0.053%
2/13/2025	Invesco Ltd.	43,435	$1.16M	0.0%	-32.9%	0.046%
2/13/2025	Russell Investments Group Ltd.	33,079	$0.88M	0.0%	N/A	0.035%
2/13/2025	Envestnet Asset Management Inc.	14,678	$0.39M	0.0%	+32.0%	0.016%
2/13/2025	Wells Fargo & Company MN	33,918	$0.91M	0.0%	+51.7%	0.036%
2/12/2025	Cinctive Capital Management LP	14,093	$0.38M	0.0%	-81.5%	0.015%
2/12/2025	Trexquant Investment LP	74,781	$2M	0.0%	N/A	0.079%
2/12/2025	Geode Capital Management LLC	1,600,571	$42.74M	0.0%	+0.1%	1.690%
2/12/2025	Franklin Resources Inc.	31,607	$0.84M	0.0%	-30.1%	0.033%
2/12/2025	Alliancebernstein L.P.	77,260	$2.06M	0.0%	+1.7%	0.082%
2/12/2025	Wellington Management Group LLP	202,893	$5.42M	0.0%	-1.2%	0.214%
2/12/2025	Schroder Investment Management Group	93,061	$2.52M	0.0%	N/A	0.098%
2/12/2025	Orion Portfolio Solutions LLC	11,928	$0.32M	0.0%	-8.3%	0.013%
2/12/2025	Pictet Asset Management Holding SA	301,241	$8.04M	0.0%	N/A	0.318%
2/12/2025	Norges Bank	47,755	$1.28M	0.0%	N/A	0.050%
2/12/2025	JPMorgan Chase & Co.	124,435	$3.32M	0.0%	-21.5%	0.131%
2/12/2025	Artisan Partners Limited Partnership	1,071,596	$28.61M	0.0%	+7.1%	1.132%
2/11/2025	EFG Asset Management North America Corp.	41,338	$1.10M	0.2%	N/A	0.044%
2/11/2025	Corebridge Financial Inc.	36,090	$0.96M	0.0%	-7.0%	0.038%
2/11/2025	Vanguard Group Inc.	4,466,849	$119.27M	0.0%	-1.1%	4.717%
2/11/2025	KLP Kapitalforvaltning AS	6,800	$0.18M	0.0%	N/A	0.007%

Data available starting January 2016

See Full Table

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

Today's Range

Now: $13.41

$12.61

$13.58

50 Day Range

MA: $21.71

$11.42

$28.13

52 Week Range

Now: $13.41

$10.60

$38.12

Volume

990,800 shs

Average Volume

1,137,018 shs

Market Capitalization

$1.40 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.32

Who are the company insiders with the largest holdings of Edgewise Therapeutics?: Edgewise Therapeutics' top insider investors include:
Orbimed Advisors Llc (Director)
Peter A Thompson (Director)
R Michael Carruthers (CFO)
Joanne M Donovan (CMO)
Alan J Russell (Insider)
Kevin Koch (CEO)
Behrad Derakhshan (Insider)
Jonathan C Fox (Director)
Marc Semigran (Insider)
John R Moore (General Counsel)
John R Moore (General Counsel)
Learn More about top insider investors at Edgewise Therapeutics.
Who are the major institutional investors of Edgewise Therapeutics?: Edgewise Therapeutics' top institutional investors include:
Rhumbline Advisers — 0.10%
GAMMA Investing LLC — 0.03%
SG Americas Securities LLC — 0.01%
Contravisory Investment Management Inc. — 0.01%
Learn More about top institutional investors of Edgewise Therapeutics stock.
Which institutional investors are buying Edgewise Therapeutics stock?: In the previous quarter, EWTX stock was bought by institutional investors including:
GAMMA Investing LLC
SG Americas Securities LLC
Contravisory Investment Management Inc.
Rhumbline Advisers
Within the last year, these company insiders have bought Edgewise Therapeutics stock:
Orbimed Advisors Llc (Director)
Peter A Thompson (Director)
R Michael Carruthers (CFO)
Learn More investors buying Edgewise Therapeutics stock.